Log In
Print this Print this


Also known as: formerly PD-DAC:Insulin

  Manage Alerts
Collapse Summary General Information
Company ConjuChem Biotechnologies Inc.
DescriptionRecombinant insulin covalently bound to recombinant human albumin with conjugate-drug affinity complex (PC-DAC) technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type I and Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today